Literature DB >> 24901893

Non-cutaneous melanoma: is there a role for (18)F-FDG PET-CT?

G Murphy1, D Hussey, U Metser.   

Abstract

Non-cutaneous melanomas (NCM) are diverse and relatively uncommon. They often differ from cutaneous melanomas in their epidemiology, genetic profile and biological behaviour. Despite the growing body of evidence regarding the utility of positron emission tomography (PET)/CT in cutaneous melanoma, the data on its use in NCM are scarce. In this review, we will summarize the existing literature and present cases from our experience with NCM to illustrate current knowledge on the potential role and limitations of fluorine-18 fludeoxyglucose PET/CT in NCM.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24901893      PMCID： PMC4112397          DOI： 10.1259/bjr.20140324

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  14 in total

1.  Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients.

Authors:  Aurélien Freton; Kimberly J Chin; Robert Raut; Lawrence B Tena; Tero Kivelä; Paul T Finger
Journal:  Eur J Ophthalmol       Date:  2012 Mar-Apr       Impact factor: 2.597

2.  Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.

Authors:  Annemarie Klingenstein; Alexander R Haug; Martin M Nentwich; Reinhold Tiling; Ulrich C Schaller
Journal:  Melanoma Res       Date:  2010-12       Impact factor: 3.599

Review 3.  Anorectal malignant melanoma: extensive 45-year review and proposal for a novel staging classification.

Authors:  Claudius Falch; Alexander Stojadinovic; Claus Hann-von-Weyhern; Mladjan Protic; Aviram Nissan; Mark B Faries; Martin Daumer; Anton J Bilchik; Avital Itzhak; Björn L D M Brücher
Journal:  J Am Coll Surg       Date:  2013-05-19       Impact factor: 6.113

4.  Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.

Authors:  Michael J Reinhardt; Alexius Y Joe; Ursula Jaeger; Andrea Huber; Alexander Matthies; Jan Bucerius; Roland Roedel; Holger Strunk; Thomas Bieber; Hans-Juergen Biersack; Thomas Tüting
Journal:  J Clin Oncol       Date:  2006-03-01       Impact factor: 44.544

5.  The value of 18F-FDG-PET/CT imaging for sinonasal malignant melanoma.

Authors:  S K Haerle; M B Soyka; D R Fischer; K Murer; K Strobel; G F Huber; D Holzmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-29       Impact factor: 2.503

6.  Interest of F-18 fluorodeoxyglucose positron emission tomography in the evaluation of vaginal malignant melanoma.

Authors:  A Oudoux; T Rousseau; B Bridji; I Resche; C Rousseau
Journal:  Gynecol Oncol       Date:  2004-12       Impact factor: 5.482

7.  (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.

Authors:  Victoria Orcurto; Alban Denys; Verena Voelter; Ann Schalenbourg; Pierre Schnyder; Leonidas Zografos; Serge Leyvraz; Angelika Bischof Delaloye; John O Prior
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

8.  MR findings of malignant melanoma of the vagina.

Authors:  W K Moon; S H Kim; M C Han
Journal:  Clin Radiol       Date:  1993-11       Impact factor: 2.350

9.  Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas.

Authors:  F Egberts; I Bergner; S Krüger; J Haag; H M Behrens; A Hauschild; C Röcken
Journal:  Ann Oncol       Date:  2013-11-24       Impact factor: 32.976

10.  Clinical impact of (18)F-FDG PET-CT in recurrent stage III/IV melanoma: a tertiary centre Specialist Skin Cancer Multidisciplinary Team (SSMDT) experience.

Authors:  Manil Subesinghe; Maria Marples; Andrew F Scarsbrook; Jonathan T Smith
Journal:  Insights Imaging       Date:  2013-09-10
View more
  6 in total

1.  Non-Cutaneous Melanoma, Findings and Prognostic Value of FDG PET/CT: A Case Series of 23 patients and review of the literature.

Authors:  Bahare Saidi; Babak Fallahi; Armaghan Fard-Esfahani; Alireza Emami-Ardekani; Mohammad Eftekhari
Journal:  Asia Ocean J Nucl Med Biol       Date:  2022

2.  Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.

Authors:  Robert M Samstein; Richard D Carvajal; Michael A Postow; Margaret K Callahan; Alexander N Shoushtari; Snehal G Patel; Nancy Y Lee; Christopher A Barker
Journal:  Head Neck       Date:  2016-04-04       Impact factor: 3.147

3.  A Rare Case of Sinonasal Malignant Melanoma - Local, Regional, and Distant Spread Accurately Detected by 18F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.

Authors:  Girish Kumar Parida; Sarthak Tripathy; Sreedharan Tripathy Arun; Madhavi Tripathi; Shamim Ahmed Shamim
Journal:  Indian J Nucl Med       Date:  2020-03-12

Review 4.  Application of Multimodal and Molecular Imaging Techniques in the Detection of Choroidal Melanomas.

Authors:  Xuying Li; Lixiang Wang; Li Zhang; Fei Tang; Xin Wei
Journal:  Front Oncol       Date:  2021-02-01       Impact factor: 6.244

Review 5.  PET-CT in Clinical Adult Oncology-VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors.

Authors:  Gabriel C Fine; Matthew F Covington; Bhasker R Koppula; Ahmed Ebada Salem; Richard H Wiggins; John M Hoffman; Kathryn A Morton
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

6.  Variable features of 18F-fluorodeoxyglucose positron emission tomography-computed tomography scan in anorectal malignant melanoma: Case reports and review articles.

Authors:  Digish Shah
Journal:  World J Nucl Med       Date:  2020-06-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.